Patents by Inventor Jeong-In Yoon

Jeong-In Yoon has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20080159975
    Abstract: The present invention provides a hair treatment composition comprising a multi-arm polyethylene glycol derivative (A) that contains two or more functional groups that may be covalently bound to amines, a hair treatment agent comprising the composition, and a method for using the same. Optionally, the composition may further comprise a polyethylene glycol derivative (B), a biocompatible polymer (C), or both, wherein the derivative (B) and polymer (C) each contains one or more functional groups that may react with the functional groups of the derivative (A).
    Type: Application
    Filed: June 28, 2007
    Publication date: July 3, 2008
    Applicant: SUNBIO, INC.
    Inventors: Kwang Nho, Chang-Min Hyun, Gun-Won Bae, So-Jeong Yoon, Min-Jung Ahn
  • Publication number: 20080152616
    Abstract: The present invention relates to an amphiphilic block copolymer of a hydrophilic block and a hydrophobic block with a terminal hydroxyl group wherein the terminal hydroxyl group of the hydrophobic bock is substituted with a tocopherol or cholesterol group. It also relates to polymeric compositions capable of forming stable micelles in an aqueous solution, comprising the amphiphilic block copolymer and a polylactic acid derivative wherein one or more ends of the polylactic acid are covalently bound to at least one carboxyl group.
    Type: Application
    Filed: October 10, 2007
    Publication date: June 26, 2008
    Inventors: Min Hyo Seo, Sa-Won Lee, Myung-Han Hyun, Jeong-Il Yu, Dong-Hoon Chang, Hye-Jeong Yoon, Jeong-Kyung Kim
  • Publication number: 20080005791
    Abstract: A computer system includes a service partition, not directly accessible to a user, having a security agent to inspect data entering and exiting the computer system on a virtual private network (VPN) tunnel, and a service partition VPN unit to communicate with a VPN gateway. The computer system also includes a user partition, accessible to a user, having a user partition VPN unit to initiate construction of the VPN tunnel with the VPN gateway. Other embodiments are described and claimed.
    Type: Application
    Filed: June 30, 2006
    Publication date: January 3, 2008
    Inventors: Ajay Gupta, Jeong Yoon, Jesse Walker, Kapil Sood, Karanvir Grewal, Hormuzd M. Khosravi
  • Patent number: 7262287
    Abstract: The present invention relates to a nucleic acid molecule comprising the HpYPS1 gene encoding H. polymorpha yapsin1, a polypeptide encoded by the nucleic acid molecule, a H. polymorpha mutant strain having reduced yapsin activity by mutation of the HpYPS gene encoding H. polymorpha yapsin1, a recombinant H. polymorpha strain expressing a foreign protein produced by introducing a gene encoding the foreign protein into the H. polymorpha mutant strain, and a process for preparing a foreign protein comprising culturing the recombinant H. polymorpha strain under conditions to express the foreign protein and isolating the foreign protein from the culture.
    Type: Grant
    Filed: June 28, 2003
    Date of Patent: August 28, 2007
    Assignees: Korea Research Institute of Bioscience and Biotechnology, Leadbio, Inc., Bioholdings Co., Ltd.
    Inventors: Hyun-Ah Kang, Sang-Ki Rhee, Min-Jeong Sohn, Jeong-Yoon Kim
  • Publication number: 20070178237
    Abstract: The invention provides a method for patterning coatings which includes the steps of: a) applying coatings onto a flat plate; b) allowing the coatings applied to the flat plate to contact with protrusions of a substrate so as to transfer portions of the coatings on the flat plate which contact with the protrusions of the substrate to the protrusions of the substrate from the flat plate, the substrate having unevenness formed with the protrusions and grooves; and c) allowing the coatings remaining on the flat plate or on the protrusions of the substrate to contact with a print surface of a print object so as to transfer the coatings to the print object. The method has simple processes, and ensures high precision and high speed in patterning functional materials, preferalby, electronic materials.
    Type: Application
    Filed: July 31, 2006
    Publication date: August 2, 2007
    Inventors: Dong Shin, Ji Kim, Dae Kim, Sung Kim, Kyung Choi, Hee Park, Jung Ahn, Jae Choi, Sang Yoo, Yoon Heo, Han Kim, Jeong Yoon
  • Publication number: 20070154766
    Abstract: The present invention relates to a collapsible metal air fuel cell, and in particular to a collapsible metal air battery capable of generating an electric power in such a manner that an active metal of aluminum and magnesium is oxidized using oxygen from the air. The collapsible metal air battery comprises a unit cell including a pair of metal frames, a rubber housing adhered to left, right and lower sides of the metal frames, a separator and air anode adhered to an outer side of the metal frame, and a plate like metal fuel electrode inserted into the interior of the metal frames.
    Type: Application
    Filed: February 16, 2004
    Publication date: July 5, 2007
    Inventors: Dong-Soo Baik, Jeong-Yoon Lee
  • Publication number: 20070128548
    Abstract: The present invention relates to a photosensitive composition comprising a triazine-based photoactive compound containing oxime ester. The photosensitive composition according to the present invention has good sensitivity, retention rate, mechanical strength, heat resistance, chemical resistance and developing durability since it contains, as photopolymerization initiator, a compound having an oxime ester group and a triazine group in one molecule and thus effectively absorbs UV radiation. Therefore, the photosensitive composition according to the present invention is advantageous not only in curing of materials for color filters, resin black matrixes, column spacers, overcoats and passivation films of liquid crystal displays, but also in high temperature process characteristics.
    Type: Application
    Filed: November 29, 2006
    Publication date: June 7, 2007
    Inventors: Sung Kim, Kyung Kim, Dong Choi, Jeong Yoon, Hee Park, Geun Cha, Keon Lee, Il Eok Kwon, Dong Oh, Jong Park, Xiang Li, Han Kim, Min Lim, Chang Cho
  • Publication number: 20070106075
    Abstract: The present invention relates to a triazine based photoactive compound containing an oxime ester group. The compound according to the present invention is a photoactive compound containing both an oxime ester group and a triazine group in one molecule, has excellent radical-generating efficiency due to effective absorption of UV radiation, particularly i-line (365 nm) radiation and can function as an effective initiator for photopolymerization of various compounds containing unsaturated groups, particularly an acryl compound.
    Type: Application
    Filed: November 6, 2006
    Publication date: May 10, 2007
    Inventors: Sung Kim, Jeong Yoon, Raisa Kharbash, Han Kim, Xiang Li, Min Lim, Chang Cho
  • Publication number: 20070059829
    Abstract: The present invention relates to compositions and method for the modulation of Wnt pathway signaling. The Wnt signaling pathway is instrumental in the regulation of cell proliferation, differentiation and morphogenesis.
    Type: Application
    Filed: August 17, 2006
    Publication date: March 15, 2007
    Inventor: Jeong Yoon
  • Patent number: 7163805
    Abstract: The present invention provides a human serum albumin-TIMP2 fusion protein having the amino acid sequence set forth in SEQ ID NO. 10, a polynucleotide encoding the same and a vector comprising the polynucleotide, a host cell transformed with the vector, a method for producing the human serum albumin-TIMP2 fusion protein and a pharmaceutical composition comprising the human serum albumin-TIMP2 fusion protein. The human serum albumin-TIMP2 fusion protein is stable and retains the activity of TIMP2, thus it can be used as a pharmaceutical composition to treat diseases related to angiogenesis and/or metastasis of cancer cells.
    Type: Grant
    Filed: July 8, 2004
    Date of Patent: January 16, 2007
    Assignees: Leadbio, Inc., Angiolab, Inc.
    Inventors: Jeong-Yoon Kim, Min-Young Kim, Eun-Kyu Park, Jae-Young Chang, Hyun Ah Kang
  • Publication number: 20060286283
    Abstract: A luminous candy functioning as both a favorite food and a lighting toy by showing a visual effect is disclosed. The luminous candy comprises: a body portion; a stick portion a portion of which is inserted into the body portion; and a luminous portion provided in the stick portion so that the light is emitted when the stick portion is bent. The body portion and the stick portion are transparent. Since the light is reflected through the body portion and the stick portion of the candy to provide unique visual effect, the curiosity and taste of the various consumers such as children, juveniles, and lovers is effectively stimulated, improving the value added of the product.
    Type: Application
    Filed: July 7, 2005
    Publication date: December 21, 2006
    Applicant: GF Co., Ltd.
    Inventor: Jeong Yoon
  • Publication number: 20060151754
    Abstract: The invention provides a variable focus liquid lens using electrowetting, comprising a conductive first liquid and an insulating second liquid. At least one of the first liquid composed of electrolyte and the second liquid composed of insulating liquid contains a surfactant for reducing interfacial energy between the first and second liquids. An interfacial portion between the first and second liquids is gathered by surfactant to reduce driving voltage. The variable focus liquid lens according to the invention has about 50% lower driving voltage required for changing focus, ensuring stability of the two fluids.
    Type: Application
    Filed: January 13, 2006
    Publication date: July 13, 2006
    Inventors: Hee Choi, Ha Jung, Jae Bae, Jong Kim, Jeong Yoon, Young Kim, Bae Kim
  • Publication number: 20060156281
    Abstract: An apparatus and a method for creating a control code for a home network appliance according to resolution of a control device which can automatically create a control code for a home network appliance according to the resolution of the control device and can perform a testing of the device even in the case in which the home network appliance is not bound.
    Type: Application
    Filed: December 20, 2005
    Publication date: July 13, 2006
    Inventors: Su-jeong Yoon, O-shik Kwon, Kwan-woo Song, Sun-hyung Kim
  • Publication number: 20050239074
    Abstract: The present invention relates to a nucleic acid molecule comprising the HpYPS1 gene encoding H. polymorpha yapsin1, a polypeptide encoded by the nucleic acid molecule, a H. polymorpha mutant strain having reduced yapsin activity by mutation of the HpYPS gene encoding H. polymorpha yapsin1, a recombinant H. polymorpha strain expressing a foreign protein produced by introducing a gene encoding the foreign protein into the H. polymorpha mutant strain, and a process for preparing a foreign protein comprising culturing the recombinant H. polymorpha strain under conditions to express the foreign protein and isolating the foreign protein from the culture.
    Type: Application
    Filed: June 28, 2003
    Publication date: October 27, 2005
    Inventors: Hyun-Ah Kang, Sang-Ki Rhee, Min-Jeong Sohn, Jeong-Yoon Kim
  • Publication number: 20050238759
    Abstract: A gum base composition including gelatin and calcium carbonate, or gelatin and talc can provide a hard gum that is stone shaped, that can be softened upon chewing. The present invention also provides a process for preparing a stone gum using the gum base composition.
    Type: Application
    Filed: April 26, 2005
    Publication date: October 27, 2005
    Inventors: Jeong Yoon, Byong Park
  • Publication number: 20050226932
    Abstract: The present invention relates to a pharmaceutical composition containing as an active ingredient, itraconazole. More particularly, the present invention relates to the pharmaceutical composition comprising itraconazole, a polylactic acid derivative, and an amphiphilic block copolymer. The polylactic acid derivative may be combined with a metal ion at the carboxylic acid terminal, and the amphiphilic block copolymer forms micelles or nano-particles in an aqueous medium.
    Type: Application
    Filed: February 1, 2005
    Publication date: October 13, 2005
    Inventors: Hye-Jeong Yoon, Min Seo, Jeong-Kyung Kim
  • Publication number: 20050201972
    Abstract: The present invention relates to an amphiphilic block copolymer of a hydrophilic block and a hydrophobic block with a terminal hydroxyl group wherein the terminal hydroxyl group of the hydrophobic bock is substituted with a tocopherol or cholesterol group. It also relates to polymeric compositions capable of forming stable micelles in an aqueous solution, comprising the amphiphilic block copolymer and a polylactic acid derivative wherein one or more ends of the polylactic acid are covalently bound to at least one carboxyl group.
    Type: Application
    Filed: October 7, 2004
    Publication date: September 15, 2005
    Inventors: Min Seo, Bong Kim, In Choi, Myung Shim, Sa-Won Lee, Myung-Han Hyun, Jeong-Il Yu, Dong-Hoon Chang, Hye-Jeong Yoon, Jeong-Kyung Kim
  • Publication number: 20050077984
    Abstract: A laminated low pass filter including a dielectric block having a plurality of laminated dielectric layers, input and output electrodes and outer ground electrodes formed on outer side surfaces of the dielectric block, so as to pass therethrough a signal inputted to the outer input electrode, only in a low frequency band, and then to output the passed signal to the outer output electrode. The laminated low pass filter also includes a transmission line including a distributed constant element made of a strip line formed on a first one of the dielectric layers, while being uniformly distributed with an inductance and a capacitance, the distributed constant element being connected between the input electrode and the output electrode, and a capacitor electrode structure having at least two layers while being connected between the input electrode and the output electrode. The capacitance electrode structure forms a capacitance connected in parallel to the transmission line.
    Type: Application
    Filed: December 16, 2003
    Publication date: April 14, 2005
    Inventors: Byoung Lee, Jeong Yoon, Yong Park, Dong Park, Sang Park, Min Park
  • Publication number: 20050079687
    Abstract: Disclosed is a method for efficiently separating a sapphire wafer serving as a substrate, on which semiconductor elements are formed, into unit chips by scribing the sapphire wafer, after grinding and lapping a rear surface of the sapphire wafer and then sand-blasting the sapphire wafer. The method includes the steps of: (a) grinding a rear surface of the sapphire wafer so that the sapphire wafer has a designated thickness; (b) lapping the rear surface of the ground sapphire wafer so that the sapphire wafer has a designated thickness; (c) polishing the rear surface of the lapped sapphire wafer so that the sapphire wafer has a designated thickness; (d) sand-blasting the rear surface of the polished sapphire wafer by uniformly blasting particles at a designated pressure during a designated time onto the rear surface of the polished sapphire wafer; and (e) scribing the rear surface of the sand-blast ground sapphire wafer.
    Type: Application
    Filed: March 23, 2004
    Publication date: April 14, 2005
    Inventors: Jeong Yoon, Bang Oh, Kuk Yi
  • Publication number: 20050048627
    Abstract: The present invention provides a human serum albumin-TIMP2 fusion protein having the amino acid sequence set forth in SEQ ID NO. 10, a polynucleotide encoding the same and a vector comprising the polynucleotide, a host cell transformed with the vector, a method for producing the human serum albumin-TIMP2 fusion protein and a pharmaceutical composition comprising the human serum albumin-TIMP2 fusion protein. The human serum albumin-TIMP2 fusion protein is stable and retains the activity of TIMP2, thus it can be used as a pharmaceutical composition to treat diseases related to angiogenesis and/or metastasis of cancer cells.
    Type: Application
    Filed: July 8, 2004
    Publication date: March 3, 2005
    Inventors: Jeong-Yoon Kim, Min-Young Kim, Eun-Kyu Park, Jae-Young Chang, Hyun Kang